Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: results from the Rotterdam Study
30 August 2020 (08:30 - 08:30)
Organised by:
About the speaker
Rotterdam (Netherlands (The))
7 More presentations in this session
Professor K. Ray (London, GB)
Doctor L. Lobo (Buenos Aires, AR)
Professor D. Bhatt (New York City, US)
Professor B. Olshansky (Iowa City, US)
Professor J. Ferrieres (Toulouse, FR)
Access the full session
The Event
ESC Congress 2020
30 August 2020
08:30 CET
